In support of improving patient care, Boston Children’s Hospital is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for the healthcare team.
Boston Children’s Hospital designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME
Boston Children’s Hospital designates this activity for 15.25 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.
MOC Part II
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 15 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program, 15 with the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, and 15 with the American Board of Anesthesiology Maintenance of Certification in Anesthesiology Program® (MOCA®). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.